<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Meet the Author

Albert Kim

Chief Medical Officer

Dr. Albert Kim has rich expertise in cardiovascular disease, translational medicine, and drug development. After receiving degrees from Harvard and UCLA, completing residency at Brigham and Women's Hospital, and undertaking further specialty training at Mass General Hospital and UCSF, he achieved board certification in internal medicine, cardiology, and clinical cardiac electrophysiology. Most recently, he was Vice President, Clinical Research Head for Pfizer’s Internal Medicine Research Unit. His roles at Pfizer and at Novartis saw him lead early and late-phase programs for common and rare diseases. Albert has contributed to development efforts for several candidate medicines utilizing different therapeutic modalities and has authored a body of work including numerous publications in leading medical journals. He was also a medical reviewer in the Division of Cardiac Devices at the FDA.

 

Featured Posts

Sorry no results please clear the filters and try again

Reinventing Clinical Trial Design: Digital Development

New medicines and devices under development live and die on the strength of their clinical data. An asset’s journey is..
Read more

Time Check: Developing New Therapeutics

Hello! I’m delighted to pen my inaugural blog post here as Cytel’s Chief Medical Officer. In this series, we’ll explore..
Read more
Load more